Stock listing
Stuttgart:SO6 Hydreight Technologies Inc Aktie
German listing (Stuttgart) of Hydreight Technologies Inc · home listing TSXV:NURS
Follow Hydreight Technologies Inc into a list and get an email when it puts out news.
Home listing price · TSXV:NURS
$3.05 CAD 0.00 (0.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:NURS
- Day range
- $2.97 – $3.15 CADNov 20, 2026
- Volume
- 30,863 sharesNov 20, 2026
- Market cap
- $163.7M CADAt the close on Nov 20, 2026 · price × 53.67M shares outstanding
- 52-week range
- $2.38 – $5.40 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $253,945 CADMedian day 52,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:NURS · Home | $3.05 CAD | 0.00 (0.0%) | 30,863 | $3.15 | $3.15 | $2.97 | $3.05 | Close on Nov 20, 2026 |
| OTC:HYDTF | $2.11 USD | -0.09 (-4.1%) | 6,438 | $2.14 | $2.14 | $2.11 | $2.20 | Close on Nov 20, 2026 |
| Frankfurt:SO6 | €1.982 EUR | +0.06 (+3.1%) | — | €1.982 | €1.982 | €1.982 | €1.922 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TSXV:NURS · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.05 | 0.00 | 0.0% | $3.15 | $3.15 | $2.97 | 30,863 | |
| $3.05 | 0.00 | 0.0% | $3.05 | $3.09 | $3.00 | 28,472 | |
| $3.05 | -0.15 | -4.7% | $3.20 | $3.20 | $3.05 | 30,068 | |
| $3.20 | +0.05 | +1.6% | $3.20 | $3.27 | $3.14 | 43,297 | |
| $3.15 | +0.08 | +2.6% | $3.10 | $3.17 | $3.00 | 20,957 | |
| $3.07 | -0.06 | -1.9% | $3.15 | $3.15 | $3.04 | 13,751 | |
| $3.13 | +0.10 | +3.3% | $3.05 | $3.16 | $3.05 | 14,872 | |
| $3.03 | -0.08 | -2.6% | $3.20 | $3.20 | $3.00 | 18,350 | |
| $3.11 | +0.11 | +3.7% | $3.05 | $3.14 | $3.03 | 19,862 | |
| $3.00 | 0.00 | 0.0% | $3.00 | $3.00 | $2.90 | 30,371 | |
| $3.00 | +0.19 | +6.8% | $2.91 | $3.00 | $2.66 | 88,762 | |
| $2.81 | -0.21 | -7.0% | $3.07 | $3.12 | $2.78 | 79,374 | |
| $3.02 | -0.12 | -3.8% | $3.15 | $3.15 | $2.87 | 106,970 | |
| $3.14 | +0.01 | +0.3% | $3.25 | $3.29 | $2.98 | 98,004 | |
| $3.13 | -0.42 | -11.8% | $3.51 | $3.54 | $3.00 | 147,832 | |
| $3.55 | +0.04 | +1.1% | $3.51 | $3.74 | $3.46 | 118,906 | |
| $3.51 | +0.385 | +12.3% | $3.16 | $3.59 | $3.11 | 94,386 | |
| $3.125 | -0.065 | -2.0% | $3.18 | $3.19 | $3.10 | 25,300 | |
| $3.19 | -0.01 | -0.3% | $3.20 | $3.20 | $3.12 | 14,235 | |
| $3.20 | +0.07 | +2.2% | $3.13 | $3.24 | $3.09 | 29,800 | |
| $3.13 | -0.13 | -4.0% | $3.24 | $3.25 | $3.09 | 14,700 | |
| $3.26 | +0.04 | +1.2% | $3.27 | $3.28 | $3.17 | 14,000 | |
| $3.22 | -0.13 | -3.9% | $3.26 | $3.35 | $3.22 | 16,300 | |
| $3.35 | -0.04 | -1.2% | $3.38 | $3.41 | $3.27 | 63,000 | |
| $3.39 | -0.06 | -1.7% | $3.45 | $3.50 | $3.37 | 52,500 | |
| $3.45 | -0.06 | -1.7% | $3.34 | $3.55 | $3.34 | 32,600 | |
| $3.51 | -0.19 | -5.1% | $3.73 | $3.73 | $3.35 | 37,800 | |
| $3.70 | +0.06 | +1.6% | $3.63 | $3.76 | $3.63 | 69,400 | |
| $3.64 | +0.18 | +5.2% | $3.46 | $3.80 | $3.46 | 72,100 | |
| $3.46 | +0.03 | +0.9% | $3.45 | $3.59 | $3.41 | 37,900 | |
| $3.43 | -0.16 | -4.5% | $3.51 | $3.52 | $3.37 | 44,300 | |
| $3.59 | +0.26 | +7.8% | $3.39 | $3.59 | $3.39 | 30,100 | |
| $3.33 | -0.16 | -4.6% | $3.49 | $3.49 | $3.30 | 28,100 | |
| $3.49 | +0.22 | +6.7% | $3.29 | $3.49 | $3.29 | 75,100 | |
| $3.27 | -0.06 | -1.8% | $3.33 | $3.33 | $3.22 | 62,800 | |
| $3.33 | +0.16 | +5.0% | $3.21 | $3.33 | $3.15 | 31,700 | |
| $3.17 | -0.08 | -2.5% | $3.26 | $3.26 | $3.08 | 26,800 | |
| $3.25 | +0.05 | +1.6% | $3.16 | $3.25 | $3.06 | 72,900 | |
| $3.20 | +0.06 | +1.9% | $3.05 | $3.24 | $2.95 | 45,100 | |
| $3.14 | +0.04 | +1.3% | $3.06 | $3.19 | $3.04 | 25,600 | |
| $3.10 | -0.08 | -2.5% | $3.18 | $3.18 | $3.05 | 48,200 | |
| $3.18 | -0.08 | -2.5% | $3.17 | $3.21 | $3.13 | 19,200 | |
| $3.26 | +0.16 | +5.2% | $3.05 | $3.35 | $3.05 | 35,000 | |
| $3.10 | -0.11 | -3.4% | $3.15 | $3.20 | $3.02 | 93,400 | |
| $3.21 | +0.18 | +5.9% | $3.05 | $3.23 | $3.05 | 78,600 | |
| $3.03 | 0.00 | 0.0% | $3.05 | $3.17 | $2.99 | 112,700 | |
| $3.03 | -0.13 | -4.1% | $3.16 | $3.19 | $2.99 | 119,800 | |
| $3.16 | -0.08 | -2.5% | $3.25 | $3.25 | $3.02 | 145,800 | |
| $3.24 | -0.04 | -1.2% | $3.28 | $3.28 | $3.18 | 40,500 | |
| $3.28 | -0.14 | -4.1% | $3.36 | $3.36 | $3.14 | 132,000 | |
| $3.42 | -0.10 | -2.8% | $3.45 | $3.50 | $3.36 | 105,800 | |
| $3.52 | -0.115 | -3.2% | $3.65 | $3.65 | $3.46 | 68,000 | |
| $3.635 | -0.075 | -2.0% | $3.73 | $3.78 | $3.52 | 64,900 | |
| $3.71 | -0.11 | -2.9% | $3.77 | $3.77 | $3.62 | 130,300 | |
| $3.82 | +0.37 | +10.7% | $3.39 | $3.88 | $3.39 | 205,400 | |
| $3.45 | -0.69 | -16.7% | $3.90 | $3.90 | $3.35 | 764,900 | |
| $4.14 | +0.17 | +4.3% | $3.97 | $4.14 | $3.95 | 63,100 | |
| $3.97 | -0.02 | -0.5% | $4.04 | $4.10 | $3.97 | 47,700 | |
| $3.99 | -0.31 | -7.2% | $4.27 | $4.27 | $3.97 | 90,600 | |
| $4.30 | +0.10 | +2.4% | $4.15 | $4.30 | $4.10 | 148,300 | |
| $4.20 | +0.36 | +9.4% | $3.84 | $4.20 | $3.83 | 75,500 | |
| $3.84 | -0.15 | -3.8% | $3.97 | $3.98 | $3.84 | 66,200 | |
| $3.99 | +0.08 | +2.0% | $3.95 | $4.03 | $3.93 | 52,100 | |
| $3.91 | -0.20 | -4.9% | $4.10 | $4.10 | $3.91 | 115,400 |
- Ticker
- Stuttgart:SO6
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 8, 2026
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology
Latest earnings call · Sep 1, 2026
Hydreight Technologies (TSXV:NURS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · June 2026
Q1 2026 Earnings Presentation
Earnings · 10 slides
Latest news
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology
Oct 8, 2026
Closed $3.46 (+0.9%) on Oct 8, 2026
Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million
Aug 31, 2026
Closed $4.14 (+4.3%) on Aug 31, 2026
Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A
Aug 27, 2026
Closed $3.99 (-7.2%) on Aug 27, 2026
Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
Aug 6, 2026
Closed $3.82 (+2.1%) on Aug 6, 2026
Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations
Jul 29, 2026
Closed $4.10 (+0.7%) on Jul 29, 2026
Hydreight Announces Refiling of Interim Financial Statements
Jun 2, 2026
Closed $4.91 (-5.6%) on Jun 3, 2026
Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
Jun 1, 2026
Closed $5.20 (+9.9%) on Jun 2, 2026
Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
Jun 1, 2026
Closed $4.73 (+11.6%) on Jun 1, 2026
Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
May 26, 2026
Closed $4.01 (+0.5%) on May 26, 2026
Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum
May 1, 2026
Closed $3.90 (-7.6%) on May 1, 2026
Issued by another party
Hydreight Technologies Inc on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 22 in the last 12 months · 49 in all · newest Oct 8, 2026 · oldest 2025
- Calls
- 6 calls with a replay · 6 with a transcript · latest Sep 1, 2026
- Decks
- 3 decks · latest June 2026
Where Hydreight Technologies Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:NURS · Home listing | TSXV | Canada | CAD |
| OTC:HYDTF | OTC | United States | USD |
| Cboe Canada:NURS | Cboe Canada | Canada | CAD |
| LS Exchange:A3D065 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3D065 | Lang & Schwarz | Germany | EUR |
| Tradegate:SO6 | Tradegate | Germany | EUR |
| Frankfurt:SO6 | Frankfurt | Germany | EUR |
| Dusseldorf:SO6 | Dusseldorf | Germany | EUR |
| Stuttgart:SO6 · This page | Stuttgart | Germany | EUR |
Valuation
P/E 24.3× against a median of 17.7×: 6th lowest of 8 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $152.5M CAD
- P/E
- 24.3×
- EV/sales
- 1.9×
- EV/EBITDA
- 17.7×
- Price/book
- 4.2×
- Gross margin
- 20.5%
- Operating margin
- 10.2%
- Net margin
- 8.6%
- Debt to equity
- 0.2×
- Beta vs S&P/TSX Composite
- 0.95
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Hydreight Technologies Inc · TSXV:NURS | US$114.1M | US$106.3M | 24.3× | 1.9× | 17.7× | 4.2× | 8.6% | 0.2× | 0.95 |
| Nordhealth AS · OSL:NORDH | US$121.9M | US$108.2M | n/a | 1.9× | 45.6× | 2.0× | −29.9% | 0.0× | n/a |
| CHC Healthcare Group · TWSE:4164 | US$121.1M | US$251.3M | 17.7× | 1.8× | 7.3× | 0.5× | 4.9% | 0.8× | n/a |
| Ekachai Medical Care Public Company Limited · SET:EKH | US$119.7M | US$99.99M | 15.0× | 2.6× | 8.3× | 1.8× | 20.9% | 0.0× | n/a |
| Honliv Healthcare Management Group Co Ltd · HKEX:9906 | US$119.4M | US$100.2M | n/a | n/a | n/a | 1.7× | n/a | 0.3× | n/a |
| GPT Healthcare Limited · NSE:GPTHEALTH | US$118.6M | US$118.6M | 23.3× | 2.2× | 12.1× | 4.1× | 9.6% | 0.0× | n/a |
| Icon Group Ltd · TASE:ICON | US$117.8M | US$193.2M | 7.8× | 0.4× | 6.5× | 1.4× | 2.9% | 0.9× | n/a |
| Alcidion Group Limited · ASX:ALC | US$113.6M | US$100.4M | 75.0× | 2.9× | 20.1× | 1.9× | 4.4% | 0.0× | n/a |
| Kindstar Globalgene Technology, Inc. · HKEX:9960 | US$111.6M | −US$99.19M | n/a | −0.7× | n/a | 0.3× | −6.3% | 0.1× | n/a |
| Auna SA · NYSE:AUNA | US$110.3M | US$1.05B | 24.8× | 0.8× | 4.3× | 0.2× | 0.3% | 2.0× | 1.03 |
| BenQ BM Holding Cayman Corp. · HKEX:2581 | US$110.2M | US$43.03M | 7.7× | 0.1× | 0.8× | 0.3× | 3.5% | 0.1× | n/a |
| Median of the others | US$118.2M | US$104.3M | 17.7× | 1.8× | 7.8× | 1.6× | 3.5% | 0.1× | 1.03 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 7.92 CAD · Analysts' mean
- EPS, year to Dec 2026
- 0.37 · 1 analyst
- Revenue, year to Dec 2026
- 145.2M · 3 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Shane Madden | Founder and CEO |
Board
| Director | Role |
|---|---|
| Shane Madden | Founder and CEO |
Events
- Next results
- Nov 26, 2026 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Hydreight Technologies (TSXV:NURS) Q2 2026 Earnings Call | Tue, Sep 01, 2026 · 9:00 AM ET | Replay |
| Hydreight Technologies (TSXV:NURS) Q1 2026 Earnings Call | Tue, Jun 02, 2026 · 9:00 AM ET | Replay |
| Hydreight Technologies (TSXV:NURS) Q4 2025 Earnings Call | Fri, May 01, 2026 · 9:00 AM ET | Replay |
| Hydreight Technologies (TSXV:NURS) Q3 2025 Earnings Call | Fri, Nov 28, 2025 · 2:00 PM ET | Replay |
| Hydreight Technologies (TSXV:NURS) Q2 2025 Earnings Call | Fri, Aug 29, 2025 · 2:00 PM ET | Replay |
| Hydreight Technologies (TSXV:NURS) Q1 2025 Earnings Call | Mon, Jun 16, 2025 · 2:00 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 31, 2026 · After close | −16.7% |
| Q1 2026 | Apr 30, 2026 · After close | −7.6% |
| Q3 2025 | Nov 26, 2025 · After close | −7.6% |
| Q2 2025 | Aug 25, 2025 · After close | +10.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2026 Earnings Presentation | Earnings | 10 slides | June 2026 |
| FY2025 Earnings Presentation | Earnings | 13 slides | May 1, 2026 |
| Investor Presentation (September 2022) | Investor deck | 18 slides | Sep 8, 2022 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Bought deal of units Closed: C$15.01M raised · C$4.05 a unit · ½ warrant at C$5.27 for 24 months · Canaccord Genuity Corp. +1 Dealers: Canaccord Genuity Corp. (lead), Beacon Securities Limited Use of proceeds: Sales growth, creating and expanding pharmacy production lines, working capital and general corporate purposes | Jan 27, 2026 | US$11.02M |
| Unsecured convertible debentures Closed: C$11.5M raised · C$1,000 · Canaccord Genuity Corp. +1 Dealers: Canaccord Genuity Corp. (lead), Beacon Securities Ltd. Use of proceeds: General corporate and working capital purposes | Sep 4, 2025 | US$8.32M |
| Private placement of units Closed: C$5.41M raised · C$1.55 a unit · 1 warrant at C$2 for 36 months · Beacon Securities Limited Dealers: Beacon Securities Limited (lead) Use of proceeds: Support sales growth, working capital and general corporate purposes | Feb 26, 2025 | US$3.78M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CAD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 35.4M | 16.0M | 11.5M | 4.27M | 1.20M | 452.7K |
| Cost of revenue | 26.4M | 10.3M | 6.55M | 2.43M | 555.6K | 134.1K |
| Gross profit | 9.00M | 5.70M | 4.96M | 1.84M | 643.8K | 318.6K |
| Research and development | 150.6K | 118.8K | ||||
| Selling, general and administrative | 5.99M | 5.48M | 5.73M | 3.11M | 991.8K | 418.8K |
| Operating income | 2.21M | 292.2K | -1.47M | -1.96M | -440.2K | -231.1K |
| Depreciation and amortization | 452.8K | 181.1K | 108.4K | 37.3K | 0 | |
| EBITDA | 2.67M | 473.3K | -1.36M | -1.92M | -440.2K | |
| Interest expense | 586.4K | 0 | 605 | 2.27K | 0 | |
| Income before tax | 1.11M | -405.2K | -1.94M | -6.00M | -516.9K | -231.1K |
| Net income | 1.69M | -405.2K | -1.94M | -6.00M | -527.8K | -231.1K |
| Earnings per share, basic | 0.04 | -0.01 | -0.05 | -0.16 | -0.01 | -0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 15.6M | 1.19M | 1.78M | 2.43M | 6.38K | 32.8K |
| Receivables | 1.68M | 47.8K | 23.8K | 5.06K | ||
| Inventory | 0 | 103.8K | 104.3K | 0 | ||
| Current assets | 20.9M | 1.58M | 2.06M | 2.62M | 46.3K | 41.3K |
| Total assets | 33.8M | 3.11M | 2.60M | 2.89M | 429.1K | 41.3K |
| Accounts payable | 1.30M | 1.01M | 1.90M | 747.5K | 404.8K | 18.0K |
| Current liabilities | 5.26M | 4.04M | 4.41M | 3.23M | 1.20M | 293.2K |
| Long-term debt | 8.36M | |||||
| Total liabilities | 14.1M | 4.88M | 4.43M | 3.25M | 1.21M | 293.2K |
| Shareholders' equity | 19.7M | -1.77M | -1.83M | -356.8K | -784.5K | -251.9K |
| Shares outstanding | 47.3M | 40.3M | 38.3M | 37.8M | 37.8M | 37.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -1.87M | 856.9K | -402.2K | -329.6K | -148.2K | 20.9K |
| Capital spending | -1.52M | -1.18M | -211.5K | -66.5K | -378.4K | 0 |
| Free cash flow | -3.38M | -325.5K | -613.7K | -396.1K | -526.6K | 20.9K |
| Cash from financing | 18.0M | -63.5K | 31.2K | 2.82M | 500.5K | -522 |
| Dividends paid | 0 | 0 | ||||
| Share buybacks | 0 | -7.42K | 0 | |||
| Change in cash | 14.5M | -596.8K | -648.6K | 2.43M | -26.4K | 32.8K |
Filings
Cap table
Built by 6ix from Hydreight Technologies Inc’s releases · as of Jan 27, 2026
- Common shares
- 53,671,430
- Fully diluted
- 59,016,230
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 53,671,430 | |
| Warrants | 5,344,800 | Jan 27, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · C$5.27 · expire about Jan 2028 |
| Warrants · C$2.00 · expire about Feb 2028 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 53,671,430 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Shane Madden | Founder and CEO · Since at least Oct 8, 2026 |
Log in to ask 6ix AI your own questions about Hydreight Technologies Inc.